HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Hermans, M. P. Articles by Turc, A. P. Articles citing this Article PubMed PubMed Citation Articles by Hermans, M. P. Articles by Turc, A. P.

Prevalence and Determinants of Impaired Glucose Metabolism in Frail Elderly Patients: The Belgian Elderly Diabetes Survey (BEDS)

¹ Endocrinology and Nutrition Unit, University Clinics St. Luc, Catholic University of Louvain, Brussels, Belgium.
² Geriatric Service, Erasme University Hospital, Free University of Brussels, Belgium.
³ Menarini S.A/N.V. Benelux, Zaventem, Belgium.
⁴ CHU Brugmann, Free University of Brussels, Belgium.

Address correspondence to T. Pepersack, Clinique de Gériatrie, Hopital Erasme, Université Libre de Bruxelles, Route de Lennik 808, B-1070 Brussels, Belgium. E-mail: tpepersa{at}ulb.ac.be

Background. Although diabetes in elderly persons is generally type 2, the metabolic abnormalities associated with aging suggest that elderly persons may differ from younger persons with type 2 diabetes. In addition, nonobese elderly persons with type 2 diabetes show a marked impairment in insulin release accompanied by mild insulin resistance, whereas obese elderly persons have marked insulin resistance in the presence of "adequate" levels of insulin. Other factors that could adversely affect glucose tolerance in aging include drug use, associated disease, and other stressful conditions commonly encountered in geriatric inpatients units. The authors' objectives in this study were 1) to prospectively assess the prevalence of glucose homeostasis abnormalities among elderly hospitalized patients and the degree to which it reflects abnormalities in insulin secretion or insulin sensitivity using homeostasis model assessment of fasting glucose, insulin, and C-peptide; and 2) to define the social, functional, pathologic, and nutritional characteristics of persons with impaired glucose tolerance or diabetes.

Methods. Ninety-eight patients underwent a comprehensive geriatric assessment. Determinants of glucose homeostasis were assessed using the homeostasis model assessment, which provides estimates of ß-cell function (%B) and insulin sensitivity (%S).

Results. Twelve patients (12%) had fasting glucose concentrations greater than 110 mg/dl. Four patients had impaired fasting glucose levels greater than 110 mg/dl but less than 126 mg/dl (IFG group), and 8 patients had levels greater than 126 mg/dl (type 2 diabetes group). Except for a higher proportion of women in the IFG-diabetes group, the latter did not exhibit significant differences in functional, morbidity, or nutritional characteristics compared with the normal glucose tolerance group. The entire cohort (n = 98) presented with a mean (±SD) %B of 71% ± 47% and a mean %S of 208% ± 198%. Compared with the normal glucose tolerance group, the IFG-diabetes group had a fasting glycemia level of 142 ± 24 mg/dl (vs 92 ± 9 mg/dl), a %B of 43% ± 21% (vs 74% ± 45%), and a mean %S of 126% ± 113% (vs 219% ± 205%).

Conclusions. These data confirm the high prevalence of impaired glucose metabolism among elderly people, although the usual risk factors were not significantly increased. Marked ß secretory defects seem to be the rule, whereas a significant degree of insulin resistance is unusual.